Contact Us
Toggle navigation
A-Z Senior Health
Mental Health
Healthy Living
Sign Up
Category:
obesity
FDA Says Shortage of GLP-1 Tirzepatide Is Over
U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose
Unhealthy, Ultra-processed Foods Now Half of Calories Americans Eat at Home
GLP-1 Meds May Lower Clot Risk in People With Diabetes
Analysis Predicts Big Drop for U.S. in Global Health Rankings
obesity
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
Alzheimers
Ozempic, Wegovy Might Help Lower Alzheimer’s Risk in People With Diabetes
obesity
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year
Alcoholism
Weight-Loss Meds Like Wegovy Could Battle Alcoholism
cancer
Obesity Could Cause 40% of Hormone-Positive Breast Cancers in Older Women
obesity
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
Diabetes
Ozempic Plus Intestinal ‘Zap’ Therapy May Eliminate Need for Insulin in Type 2 Diabetics
fitness-exercise
Could Certain Genes Help You Slim Down?
Health Insurance
Only 1 in 5 Large Companies’ Health Plans Cover New Weight-Loss Meds for Employees
cancer
Six in 10 Americans Have Unhealthy Pro-Inflammatory Diets
More Articles